Assessment templates and guidance

The documents provide general guidance on the evaluation of the quality , non-clinical and clinical aspects of new drug applications and extension applications.

CHMP, CAT and (Co)Rapporteurs should circulate the assessment reports and comments via   Eudralink.

Assessors should always submit assessment reports and comments for initial marketing authorisation applications to:

  • the EMA product lead and product assistant (whose names are listed on the dashboard for national competent authorities);
  • the product shared mailbox (whose format is always 'product name-product number' in one word, followed by '@ema.europa.eu');
  • the product's dedicated initial MAA mailbox (whose format is always 'MAAproduct number' in one word, followed by '@ema.europa.eu').

The product number is always composed of 4 digits including xxxx if needed.

Assessors should have the Agency's styles installed in Microsoft Word to ensure optimal use of the templates.

For technical support with using the templates, please use  EMA service desk .

To raise other queries or comments about the templates, please contact  [email protected]

Day 80 and Day 120 assessment report templates (containing guidance)

Day 80 assessment report - Quality template with guidance - Rev. 05. 21

English (EN) (143.11 KB - DOCX)

Annex 1 - Active substance master file (ASMF) assessment report template - Applicant's part rev. 07.18

English (EN) (34.73 KB - DOCX)

Annex 1 - Active substance master file (ASMF) assessment report template - Restricted part rev. 06.17

English (EN) (41.67 KB - DOCX)

Day 80 assessment report - Non-clinical template with guidance - Rev.10.23 Revamp

English (EN) (154.04 KB - DOCX)

Day 80 assessment report - Clinical template with guidance - Rev.04.24 Revamp

English (EN) (697.58 KB - DOCX)

Day 80 assessment report - New active substance status template - Rev. 03. 23

English (EN) (44.04 KB - DOCX)

Day 80 assessment report - Overview and D120 LOQ template with guidance - Rev. 10.23

English (EN) (233.58 KB - DOCX)

Peer reviewers comments at day 100

English (EN) (33.84 KB - DOCX)

  • Note: instructions on how to delete green guidance text is in the cover page of the assessment report template. 

Day 100 member states' and peer review comments

CHMP-CAT-PRAC member comments on rapporteur’s reports

English (EN) (32.03 KB - DOCX)

Day 150 or Day 195 joint assessment report templates and Day 180 CHMP list of outstanding issues

Day 150 or Day 195 joint assessment report - Quality template - Rev. 05. 21

English (EN) (34.15 KB - DOCX)

Day 150 or Day 195 joint response assessment report - Non-clinical template - Rev. 05. 21

English (EN) (32.02 KB - DOCX)

Day 150 or Day 195 joint response assessment report - Clinical template - Rev. 05. 21

English (EN) (35.22 KB - DOCX)

Day 150 or Day 195 joint response assessment report - Overview and list of outstanding issues template - Rev. 10.23

English (EN) (119.59 KB - DOCX)

Re-examination assessment report templates

(Co) Rapporteur (joint) assessment report of the grounds for the re-examination procedure - Rev. 05.21

English (EN) (45.5 KB - DOCX)

Informed consent assessment report template

Informed consent application in accordance with Article 10c of Directive 2001/83/EC - Rev. 05. 21

English (EN) (89.23 KB - DOCX)

Generic and hybrid medicinal products assessment report templates (containing guidance)

Generics - Hybrids - Day 80 assessment report - Quality template with guidance - Rev. 05. 21

English (EN) (78.78 KB - DOCX)

Generics - Hybrids - Day 80 assessment report - Non-clinical and clinical template with guidance - Rev. 05. 21

English (EN) (76.55 KB - DOCX)

Generics - Hybrids - Day 80 assessment report overview and D 120 list of outstanding issues template with guidance - Rev. 05. 21

English (EN) (132.5 KB - DOCX)

Generics - Hybrids - Day 150 or Day 195 joint report assessment report - Overview and D180 list of outstanding issues template with guidance - Rev. 05. 21

English (EN) (96.94 KB - DOCX)

Similarity assessment

CHMP and rapporteurs' joint assessment report on derogation applicable to similar orphan products - Rev. 03.23

English (EN) (140.49 KB - DOCX)

CHMP and Rapporteurs' assessment report template on Similarity Rev. 03.23

English (EN) (53.28 KB - DOCX)

Other templates

Certification evaluation report

English (EN) (210 KB - DOC)

Peer review of the certification procedure

English (EN) (126.5 KB - DOC)

CHMP/CAT member comments on rapporteurs’ reports

English (EN) (33.47 KB - DOCX)

  • Assessment templates and guidance for an ancillary medicinal substance incorporated in a medical device

PRAC RMP assessment report template for initial marketing authorisation application and extension applications

PRAC D94 Rapporteur RMP assessment report template rev. 01.23

English (EN) (76.78 KB - DOCX)

Quick Response (QR) code

English (EN) (54 KB - DOC)

Companion diagnostics ('in-vitro diagnostics')

Consultation on companion diagnostic - Assessment report template

English (EN) (140.95 KB - DOCX)

For more information:

  • Companion diagnostics ('in-vitro diagnostics')

Paediatric guidance

Structured guidance on the use of extrapolation

English (EN) (686.03 KB - PDF)

  • Regulatory and procedural guidance

Share this page

EMA

European Medicines Agency ©1995-2024 | Disclaimer | For technical support, please visit the EMA Service Desk (ServiceNow) portal using your user credentials for a system hosted by EMA (except Eudravigilance). If you do not have an account or have forgotten your credentials, please click here

  • No category

Template - European Medicines Agency

template table cover letter european medicines agency

Related documents

Template for DCP Request

Add this document to collection(s)

You can add this document to your study collection(s)

Add this document to saved

You can add this document to your saved list

Suggest us how to improve StudyLib

(For complaints, use another form )

Input it if you want to receive answer

IMAGES

  1. template table cover letter

    template table cover letter european medicines agency

  2. 5 Easy Steps to Cover Letter Success

    template table cover letter european medicines agency

  3. Doctor Cover Letter Example, Template, & Writing Guide

    template table cover letter european medicines agency

  4. Cover letter for Insurance agents in health care

    template table cover letter european medicines agency

  5. template table cover letter

    template table cover letter european medicines agency

  6. Clinical Nurse Consultant Cover Letter Examples

    template table cover letter european medicines agency

COMMENTS

  1. Updated formatted table template for dossier submission available

    All companies submitting procedural information to the European Medicines Agency are reminded to insert the formatted table template in their cover letter. The formatted table template is used by companies when they submit information on a medicine to the Agency. It is intended to systematically structure and label the information provided.

  2. Forms and templates

    Forms and templates; Forms and templates. Pre-submission interaction letter of intent form. Legal effective date: 22/04/2015 Reference Number: Version 1.0.4 Summary: ... European Medicines Agency Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands. Tel: +31 (0)88 781 6000.

  3. Assessment templates and guidance

    The documents provide general guidance on the evaluation of the quality, non-clinical and clinical aspects of new drug applications and extension applications.. CHMP, CAT and (Co)Rapporteurs should circulate the assessment reports and comments via Eudralink.. Assessors should always submit assessment reports and comments for initial marketing authorisation applications to:

  4. template table cover letter

    05 February 2016 Information Management Division, Version 4 Formatted table template To be inserted in each procedural submission cover letter. 1* Applicant/MAH Name 2* Customer Account Number 3* Customer Reference / Purchase 000060xxxx (only one number for WS and IG) Order Number 4 INN / Active substance 5 Product Name of centrally authorised medicinal product(s) 5.1* Nationally Authorised ...

  5. Applications for Marketing Authorisation

    Template for applicants to prepare report on similarity with authorised orphan medicinal products Template: Similarity report (September 2022) For the United Kingdom, as of 1 January 2021, European Union law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland / NI.

  6. Clinical Trials Coordination Group (CTCG)

    A high-quality cover letter will facilitate validation and assessment. This also applies to the List of Changes to be submitted as a response to the RFI. Templates for transition trials can be found under section Guidance-Transitional trials. CTCG provides the following templates, to be used in different situations: Initial application cover ...

  7. DOC EMA

    is submitting information in the enclosed table on paediatric study completed after 26 January 2007. Name of the medicinal product(s): ... Cover Letter Art 46 of Reg 1901/2006 <Product Name> Page 2/3. ... Last modified by: Johansson Tommy Created Date: 3/18/2015 11:34:00 AM Company: European Medicines Agency Other titles: EMA - Proposed update ...

  8. eSubmission: Projects

    Formatted Table Template implementation in the XML delivery files ... and after this it will be optional for applicants to provide the Formatted Template as a part of the Cover Letter in Module 1 of eCTD sequences or Part 1 of VNeeS dossier. ... All European Medicines Agency (EMA) information technology (IT) systems will be temporarily ...

  9. PDF D5.1 Submission Dossier Template Medicinal Products

    Within the submission dossier table templates are provided up to section 5.1. Table templates for the following sections (Section 5.2 et seq.) are provided in a separate file with table ... EMA European Medicines Agency EU European Union HaDEA European Health and Digital Executive Agency HTA Health Technology Assessment HTAR Regulation (EU ...

  10. Template

    Template - European Medicines Agency. advertisement ... The Table of Changes should be included as a separate document to the main Submission Cover Letter. The ASMF holder should use the following example templates for the table. If the changes have been previously authorised in a National or European procedure, the ASMF holder should annotate ...